pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›TENOFOVIR DISOPROXIL FUMARATE
drug
save

TENOFOVIR DISOPROXIL FUMARATE

Marketedupdated 3mo ago
by Hetero USA Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval4 co-mentions · 2 sources
  • drugEMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE2 co-mentions · 1 sources
  • drugEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE2 co-mentions · 1 sources
  • tagSmall Molecule2 co-mentions · 2 sources
  • drugemtricitabine2 co-mentions · 1 sources
  • druglamivudine1 co-mentions · 1 sources
  • drugEpivir-HBV1 co-mentions · 1 sources
  • companyLupin Ltd1 co-mentions · 1 sources

all catalysts(1)

approval · 1
Dec 18, 2025
approval
8mo ago
TENOFOVIR DISOPROXIL FUMARATE — FDA approval
TENOFOVIR DISOPROXIL FUMARATE
→

Trials studying TENOFOVIR DISOPROXIL FUMARATE

  • —Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Preventionrecruitingn=3,000
  • phase2Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patientscompletedn=30
  • phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)active not recruitingn=181
  • phase4The COMBAT HBV Feasibility Trialcompletedn=317
  • phase1Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamidenot yet recruitingn=64
  • phase3Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatmentrecruitingn=150
  • phase2Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)active not recruitingn=253
  • phase2Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)active not recruitingn=268
more trials →

News(0)

no news has mentioned this drug yet

brand
TENOFOVIR DISOPROXIL FUMARATE
generic
TENOFOVIR DISOPROXIL FUMARATE
indication
Hepatitis B
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 39m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?